Role of Stem Cells in Human Uterine Leiomyoma Growth
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Uterine leiomyoma is the most common benign tumor in reproductive-age women. Each leiomyoma is thought to be a benign monoclonal tumor arising from a single transformed myometrial smooth muscle cell; however, it is not known what leiomyoma cell type is responsible for tumor growth. Thus, we tested the hypothesis that a distinct stem/reservoir cell-enriched population, designated as the leiomyoma-derived side population (LMSP), is responsible for cell proliferation and tumor growth. PRINCIPAL FINDINGS: LMSP comprised approximately 1% of all leiomyoma and 2% of all myometrium-derived cells. All LMSP and leiomyoma-derived main population (LMMP) but none of the side or main population cells isolated from adjacent myometrium carried a mediator complex subunit 12 mutation, a genetic marker of neoplastic transformation. Messenger RNA levels for estrogen receptor-α, progesterone receptor and smooth muscle cell markers were barely detectable and significantly lower in the LMSP compared with the LMMP. LMSP alone did not attach or survive in monolayer culture in the presence or absence of estradiol and progestin, whereas LMMP readily grew under these conditions. LMSP did attach and survive when directly mixed with unsorted myometrial cells in monolayer culture. After resorting and reculturing, LMSP gained full potential of proliferation. Intriguingly, xenografts comprised of LMSP and unsorted myometrial smooth muscle cells grew into relatively large tumors (3.67 ± 1.07 mm(3)), whereas xenografts comprised of LMMP and unsorted myometrial smooth muscle cells produced smaller tumors (0.54 ± 0.20 mm(3), p<0.05, n = 10 paired patient samples). LMSP xenografts displayed significantly higher proliferative activity compared with LMMP xenografts (p<0.05). CONCLUSIONS: Our data suggest that LMSP, which have stem/reservoir cell characteristics, are necessary for in vivo growth of leiomyoma xenograft tumors. Lower estrogen and progesterone receptor levels in LMSP suggests an indirect paracrine effect of steroid hormones on stem cells via the mature neighboring cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For the stimulation of clonal expansion and growth of leiomyoma, sex steroids and steroid hormone receptors are necessary; yet, leiomyoma stem cells express barely detectable levels of ESR1 or PGR (Mas et al., 2012;Ono et al., 2012).”
From Endometriosis and nuclear receptors (2019) · cites this paper as Ono et al., 2012
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The relationship between the spleen colony-forming cell and the haemopoietic stem cell.
Schofield, R. (1978) · PubMed · Cited by 2,333
Tie2/Angiopoietin-1 Signaling Regulates Hematopoietic Stem Cell Quiescence in the Bone Marrow Niche
Arai, F., Hirao, A., Ohmura, M., Sato, H., Matsuoka, S., Takubo, K., Ito, K., Koh, G. Y., & Suda, T. (2004) · Cell · doi:10.1016/j.cell.2004.07.004 · Cited by 1,974
Jordan, C. T., Guzman, M. L., & Noble, M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra061808 · Cited by 1,702
Stewart, E. A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03622-9 · Cited by 1,031
Etiology, symptomatology, and diagnosis of uterine myomas
Parker, W. H. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.01.093 · Cited by 721 · cited 1×
“Several recurrent genetic aberrations, such as trisomy of chromosome 12, deletions in 7q, and mutation affecting the mediator complex subunit 12 (MED12) or the high mobility group AT-hook 2 (HMGA2) gene were reported in uterine leiomyomas [15,16,17,18].”
BackgroundControl of mammary stem cell function by steroid hormone signalling
Asselin-Labat, M.-L., Vaillant, F., Sheridan, J. M., Pal, B., Wu, D., Simpson, E. R., Yasuda, H., Smyth, G. K., Martin, T. J., Lindeman, G. J., et al. (2010) · Nature · doi:10.1038/nature09027 · Cited by 693 · cited 1×
“In mammary structures of humans and mice, mammary stem cells, despite being void of ESR1 and PGR themselves, are subject to regulation in both number and repopulating ability by steroid hormones, particularly progesterone [40,41,42,43].”
BackgroundProgesterone induces adult mammary stem cell expansion
Joshi, P. A., Jackson, H. W., Beristain, A. G., Di Grappa, M. A., Mote, P. A., Clarke, C. L., Stingl, J., Waterhouse, P. D., & Khokha, R. (2010) · Nature · doi:10.1038/nature09091 · Cited by 689 · cited 1×
“In mammary structures of humans and mice, mammary stem cells, despite being void of ESR1 and PGR themselves, are subject to regulation in both number and repopulating ability by steroid hormones, particularly progesterone [40,41,42,43].”
BackgroundMED12 , the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomas
Mäkinen, N., Mehine, M., Tolvanen, J., Kaasinen, E., Li, Y., Lehtonen, H. J., Gentile, M., Yan, J., Enge, M., Taipale, M., et al. (2011) · Science · doi:10.1126/science.1208930 · Cited by 658 · cited 3×
“MED12 mutations demonstrate that LMSP are committed to a leiomyoma cell lineage Recently, mutations in the MED12 gene have been reported in the majority of leiomyoma tissues and cells [16].”
BackgroundUterine Fibroids: The Elephant in the Room
Walker, C. L., & Stewart, E. A. (2005) · Science · doi:10.1126/science.1112063 · Cited by 547 · cited 1×
“Uterine leiomyomas, the most common pelvic tumor in women, are benign smooth muscle tumors originating from the myometrium”
BackgroundUterine Myomas: An Overview of Development, Clinical Features, and Management
Wallach, E. E., & Vlahos, N. F. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000136079.62513.39 · Cited by 540 · cited 2×
“Uterine leiomyomas are also an important cause of infertility and they are the most common medical reason for hysterectomy [3,4].”
Background
Cited by
Bulun, S. E. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1209993 · Cited by 703
Self-citationStewart, E. A., Laughlin-Tommaso, S. K., Catherino, W. H., Lalitkumar, S., Gupta, D., & Vollenhoven, B. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.43 · Cited by 531
Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer
Kim, J. J., Kurita, T., & Bulun, S. E. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1043 · Cited by 520
Self-citationMenstruation: science and society
Critchley, H. O. D., Babayev, E., Bulun, S. E., Clark, S., Garcia-Grau, I., Gregersen, P. K., Kilcoyne, A., Kim, J.-Y. J., Lavender, M., Marsh, E. E., et al. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.06.004 · Cited by 448
Self-citationComprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment
Yang, Q., Ciebiera, M., Bariani, M. V., Ali, M., Elkafas, H., Boyer, T. G., & Al-Hendy, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab039 · Cited by 425
Endometriosis and nuclear receptors
Yilmaz, B. D., & Bulun, S. E. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz005 · Cited by 243
“For the stimulation of clonal expansion and growth of leiomyoma, sex steroids and steroid hormone receptors are necessary; yet, leiomyoma stem cells express barely detectable levels of ESR1 or PGR (Mas et al., 2012; Ono et al., 2012).”
BackgroundSelf-citationComplex networks of multiple factors in the pathogenesis of uterine leiomyoma
Islam, M. S., Protic, O., Stortoni, P., Grechi, G., Lamanna, P., Petraglia, F., Castellucci, M., & Ciarmela, P. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.03.007 · Cited by 212
“It is reported that side population in human uterine myometrium displays phenotypic and functional characteristics of myometrial stem cells (222); and leiomyoma-derived side populations, which have stem cell characteristics, are necessary for in vivo growth of leiomyoma xenograft tumors (224).”
BackgroundHuman Cancer Growth and Therapy in Immunodeficient Mouse Models
Shultz, L. D., Goodwin, N., Ishikawa, F., Hosur, V., Lyons, B. L., & Greiner, D. L. (2014) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top073585 · Cited by 212
“…Quintana et al. 2008; Boonyaratanakornkit et al. 2010; Ma et al. 2010; Quintana et al. 2010; Kupas et al. 2011 Ovarian Bankert et al. 2011; Stewart et al. 2011 Prostate Goldstein et al. 2010 Sarcoma Seitz et al. 2010; Edris et al. 2012a; Ono et al. 2012; Zhang et al. 2012b Bladder Lin et al. 2013”
Uterine Leiomyoma: Available Medical Treatments and New Possible Therapeutic Options
Islam, M. S., Protic, O., Giannubilo, S. R., Toti, P., Tranquilli, A. L., Petraglia, F., Castellucci, M., & Ciarmela, P. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3237 · Cited by 200
“Later, this group found that leiomyoma-derived side populations, which have stem/reservoir cell characteristics, are necessary for in vivo growth of leiomyoma xenograft tumors (59).”
BackgroundParacrine activation of WNT/β-catenin pathway in uterine leiomyoma stem cells promotes tumor growth
Ono, M., Yin, P., Navarro, A., Moravek, M. B., Coon, J. S., Druschitz, S. A., Serna, V. A., Qiang, W., Brooks, D. C., Malpani, S. S., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313650110 · Cited by 186
“Our work has relied on Hoechst 33342-based isolation of SP cells to study stem/reservoir cell biology in uterine LM (10, 13, 14, 41).”
BackgroundMethodResultSelf-citationSegars, J. H., Parrott, E. C., Nagel, J. D., Guo, X. C., Gao, X., Birnbaum, L. S., Pinn, V. W., & Dixon, D. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt058 · Cited by 186
“Leiomyoma-derived side Comprise ~1% of all mRNA levels for ERa and PR are Stem/reservoir cell population (LMSP) stem/ leiomyoma- and 2% of minimally detectable in LMSP cells characteristics, are reservoir cells myometrium-derived cells (Ono et al., 2012) necessary for in vivo growth (Ono et al.”
BackgroundInfluentialHormones and pathogenesis of uterine fibroids
Reis, F. M., Bloise, E., & Ortiga-Carvalho, T. M. (2016) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2015.11.015 · Cited by 172
“However, LMSP did attach and survive when cultured together with leiomyoma-derived main population (LMMP), without hormonal exposure [5], demonstrating that factors derived from differentiated LMMP cells, other than steroid hormones, are necessary to promote growth and survival of LMSP in culture.”
BackgroundThe role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy
Tal, R., & Segars, J. H. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt042 · Cited by 159
“Upon implantation into immunodeficient mice, these myometrial stem cells were shown to form large leiomyoma tumors with higher proliferative activity than regular myometrial cells which formed much smaller tumors (Ono et al., 2012), suggesting that myometrial stem cellsmaybe critical for leiomyomadevelopment.”
BackgroundOvarian steroids, stem cells and uterine leiomyoma: therapeutic implications
Moravek, M. B., Yin, P., Ono, M., Coon V, J. S., Dyson, M. T., Navarro, A., Marsh, E. E., Chakravarti, D., Kim, J. J., Wei, J.-J., et al. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmu048 · Cited by 157
“however, the leiomyoma stem cell population is likely essential for steroid-dependent leiomyoma growth (Mas et al., 2012; Ono et al., 2012).”
BackgroundInfluentialSelf-citationUterine stem cells: from basic research to advanced cell therapies
Santamaria, X., Mas, A., Cervelló, I., Taylor, H., & Simon, C. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmy028 · Cited by 147
“Genetic abnormalities affecting specific TICs might play pivotal roles in the tumourigenesis of uterine leiomyoma (Ono et al., 2012) (Fig.”
BackgroundInfluentialThe Mechanism and Function of Epigenetics in Uterine Leiomyoma Development
Yang, Q., Mas, A., Diamond, M. P., & Al-Hendy, A. A. (2016) · Reproductive Sciences · doi:10.1177/1933719115584449 · Cited by 167
Mediator kinase module and human tumorigenesis
Clark, A. D., Oldenbroek, M., & Boyer, T. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1064854 · Cited by 135
“Finally, stem/progenitor cells isolated from patient-derived MED12-mutant UL are tumorigenic in murine transplantation xenograft models (Ono et al., 2012).”
Holdsworth‐Carson, S. J., Zaitseva, M., Vollenhoven, B. J., & Rogers, P. A. W. (2013) · Molecular Human Reproduction · doi:10.1093/molehr/gat083 · Cited by 125
“SMC (Chang et al., 2010; Mas et al., 2012; Ono et al., 2012).”
BackgroundMaekawa, R., Sato, S., Yamagata, Y., Asada, H., Tamura, I., Lee, L., Okada, M., Tamura, H., Takaki, E., Nakai, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066632 · Cited by 109
“reported that side population cells in the myometrium and leiomyoma tissues act as tissue stem cells and have the potential to differentiate and proliferate [37,38].”
BackgroundMolecular and Cellular Insights into the Development of Uterine Fibroids
Machado-Lopez, A., Simón, C., & Mas, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168483 · Cited by 122
George, J. W., Fan, H., Johnson, B. K., Carpenter, T. J., Foy, K. K., Chatterjee, A., Patterson, A. L., Koeman, J. M., Adams, M., Madaj, Z., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.077 · Cited by 92
“KLF4, one of the Yamanaka pluripotency-inducing factors, could also silenced by DNA methylation in fibroids (Figure 5C), which is consistent with a diminished role of stem cells in fibroids (Chang et al., 2010; Ono et al., 2012).”
Human Uterine Leiomyoma Stem/Progenitor Cells Expressing CD34 and CD49b Initiate Tumors In Vivo
Yin, P., Ono, M., Moravek, M. B., Coon, J. S., Navarro, A., Monsivais, D., Dyson, M. T., Druschitz, S. A., Malpani, S. S., Serna, V. A., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2134 · Cited by 90
Self-citationEndocrine-disrupting chemicals and uterine fibroids
Katz, T. A., Yang, Q., Treviño, L. S., Walker, C. L., & Al-Hendy, A. A. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.08.023 · Cited by 97
“TICs derived from UFs have stem cell characteristics, and are proliferative, give rise to tumors in vivo (90,95) and comprise~1% of UF cells, (99).”
BackgroundInfluentialLiterature Review on the Role of Uterine Fibroids in Endometrial Function
Ikhena, D. E., & Bulun, S. E. (2017) · Reproductive Sciences · doi:10.1177/1933719117725827 · Cited by 92
“Additionally, some fibroid stem cells possessMED12mutations that have not been identified in the myometrial stem cell population.(10) Introduction of a MED12 mutation in murine uterine tissue has been shown to give rise to fibroid-like tumor formation.”
BackgroundSelf-citationChronic Inflammation May Enhance Leiomyoma Development by the Involvement of Progenitor Cells
Orciani, M., Caffarini, M., Biagini, A., Lucarini, G., Carpini, G. D., Berretta, A., Primio, R. D., & Ciavattini, A. (2018) · Stem Cells International · doi:10.1155/2018/1716246 · Cited by 89
Fibroid growth and medical options for treatment
Chabbert‐Buffet, N., Esber, N., & Bouchard, P. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.07.1238 · Cited by 96
Endocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution
Moravek, M. B., & Bulun, S. E. (2015) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000185 · Cited by 105
“Despite the fact that fibroids contain lesser stem cells than the myometrium [73], there is evidence that the fibroid stem cell population is essential for steroid hormonedependent fibroid growth [71,72].”
BackgroundInfluentialSelf-citationRole of Medical Management for Uterine Leiomyomas
Kashani, B. N., Centini, G., Morelli, S. S., Weiss, G., & Petraglia, F. (2015) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2015.11.016 · Cited by 99
Inhibition of canonical WNT signaling attenuates human leiomyoma cell growth
Ono, M., Yin, P., Navarro, A., Moravek, M. B., Coon, J. S., Druschitz, S. A., Gottardi, C. J., & Bulun, S. E. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.01.017 · Cited by 78
“We isolated leiomyoma cells using a technique that was previously described (35, 36).”
BackgroundMethodSelf-citationStro-1/CD44 as putative human myometrial and fibroid stem cell markers
Mas, A., Nair, S., Laknaur, A., Simón, C., Diamond, M. P., & Al-Hendy, A. A. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.04.021 · Cited by 72
“This is consistent with prior reports using the SP approach (12, 18).”
BackgroundYang, Q., Madueke-Laveaux, O. S., Cun, H. T., Włodarczyk, M., Garcia, N., Carvalho, K. C., & Al-Hendy, A. A. (2024) · Cells · doi:10.3390/cells13131106 · Cited by 74
Ali, M. K., Ciebiera, M., Vafaei, S., Alkhrait, S., Chen, H.-Y., Chiang, Y., Huang, K., Feduniw, S., Hsia, S., & Al-Hendy, A. A. (2023) · Cells · doi:10.3390/cells12081117 · Cited by 87
“Several groups reported that SP cells from human UFs exhibit key features of the tumor-initiating cells [4,45].”
BackgroundYang, Q., Diamond, M. P., & Al-Hendy, A. A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00040 · Cited by 63
Sabeh, M. E., Saha, S. K., Afrin, S., Islam, M. S., & Borahay, M. A. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04174-6 · Cited by 67
“Our previous study demonstrated that simvastatin, an FDA-approved anti-hypercholesterolemia drug, has a potential inhibitory effect on UL cell proliferation and growth and ECM production in vitro and in vivo via various signaling pathways [198–202].”
BackgroundInfluentialMas, A., Stone, L., O'Connor, P. M., Yang, Q., Kleven, D. T., Simón, C., Walker, C. L., & Al-Hendy, A. A. (2016) · Stem Cells · doi:10.1002/stem.2519 · Cited by 55
Epigenomic and enhancer dysregulation in uterine leiomyomas
Mlodawska, O. W., Saini, P., Parker, J. B., Wei, J., Bulun, S. E., Simon, M. A., & Chakravarti, D. (2022) · Human Reproduction Update · doi:10.1093/humupd/dmac008 · Cited by 60
Self-citationBulun, S. E., Yin, P., Wei, J., Zuberi, A., Iizuka, T., Suzuki, T., Saini, P., Goad, J., Parker, J. B., Adli, M., et al. (2025) · Physiological Reviews · doi:10.1152/physrev.00010.2024 · Cited by 71
Self-citationMas, A., Cervelló, I., Fernández-Álvarez, A. J., Faus, A., Díaz, A., Burgués, O., Casado, M., & Simón, C. (2014) · Molecular Human Reproduction · doi:10.1093/molehr/gau114 · Cited by 44
“TICs carry mediator complex subunit 12 (MED12) mutations, suggesting one genetic mutation interacts with the stem cell that might transform myometrial toward leiomyoma cells (Ono et al., 2012) bridging the gap between both hypotheses.”
BackgroundInfluentialOrigin of Uterine Fibroids: Conversion of Myometrial Stem Cells to Tumor-Initiating Cells
Elkafas, H., Qiwei, Y., & Al-Hendy, A. A. (2017) · Seminars in Reproductive Medicine · doi:10.1055/s-0037-1607205 · Cited by 53
The Krüppel-like factors in female reproductive system pathologies
Simmen, R. C. M., Heard, M. E., Simmen, A. M., Montales, M. T. E., Marji, M., Scanlon, S. A., & Pabona, J. M. P. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0310 · Cited by 45
“Similarly, a small population of cells (approximately 1% of tumor cells) showing stem-progenitor properties was found to be essential for estrogenCprogesterone-dependent growth of uterine leiomyomas (Ono et al. 2012).”
Elkafas, H., Ali, M. K., Morsy, E. M. E., Kamel, R., Thompson, W. E., Badary, O. A., Al-Hendy, A. A., & Yang, Q. (2020) · Cells · doi:10.3390/cells9061459 · Cited by 45
“[22], Furthermore, genetic instabilities, including chromosomal loss and rearrangement,”
BackgroundProtic, O., Islam, M. S., Greco, S., Giannubilo, S. R., Lamanna, P., Petraglia, F., Ciavattini, A., Castellucci, M., Hinz, B., & Ciarmela, P. (2017) · Seminars in Reproductive Medicine · doi:10.1055/s-0037-1607265 · Cited by 48
Differences in the cellular composition of small versus large uterine fibroids
Holdsworth‐Carson, S. J., Zhao, D., Cann, L. M., Bittinger, S. E., Nowell, C. J., & Rogers, P. A. W. (2016) · Reproduction · doi:10.1530/rep-16-0216 · Cited by 46
Potential Mechanisms of Aberrant DNA Hypomethylation on the X Chromosome in Uterine Leiomyomas
Sato, S., Maekawa, R., Yamagata, Y., Asada, H., Tamura, I., Lifa, L. E. E., Okada, M., Tamura, H., & Sugino, N. (2013) · Journal of Reproduction and Development · doi:10.1262/jrd.2013-095 · Cited by 37
“MED12 exon2 genomic sequencing MED12 in leiomyoma and myometrium specimens was sequenced as described previously with some modifications [30, 33].”
MethodOno, M., Kajitani, T., Uchida, H., Arase, T., Oda, H., Nishikawa-Uchida, S., Ota, K., Nagashima, T., Masuda, H., Miyazaki, K., et al. (2015) · Biology of Reproduction · doi:10.1095/biolreprod.114.127126 · Cited by 37
“Recently, it has been reported that SP cells are also present in leiomyoma [33, 37, 38] and that leiomyoma SP cells may have the potential to behave as leiomyomainitiating cells [33, 38].”
BackgroundSelf-citationTissue-Specific Stem Cells in the Myometrium and Tumor-Initiating Cells in Leiomyoma1
Ono, M., Bulun, S. E., & Maruyama, T. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.114.123794 · Cited by 46
“suggesting that the action of steroid hormones on leiomyoma stem cells is mediated by myometrial cells in a paracrine fashion [54, 57].”
BackgroundInfluentialSelf-citationCurrent and Emerging Treatment Options for Uterine Fibroids
Ali, M. K., Ciebiera, M., Włodarczyk, M., Alkhrait, S., Maajid, E., Yang, Q., Hsia, S., & Al-Hendy, A. A. (2023) · Drugs · doi:10.1007/s40265-023-01958-6 · Cited by 43
Role of Hormones in Common Benign Uterine Lesions: Endometrial Polyps, Leiomyomas, and Adenomyosis
Kossaï, M., & Penault-Llorca, F. M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38474-6_3 · Cited by 48
Cell cultures in uterine leiomyomas: Rapid disappearance of cells carrying MED12 mutations
Markowski, D. N., Tadayyon, M., Bartnitzke, S., Belge, G., Helmke, B. M., & Bullerdiek, J. (2014) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22142 · Cited by 32
“In vitro propagation, though apparently leading to the reduction of important gene activities, offers another widely used alternative to understand the growth and behavior of UL (Draeger et al., 1993; Kwon et al., 2008; Chang et al. 2010; Mas et al., 2012; Ono et al., 2012, 2013).”
Current understanding of somatic stem cells in leiomyoma formation
Mas, A., Cervelló, I., Gil-Sanchís, C., & Simón, C. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.04.051 · Cited by 31
“In 2012, two independent groups demonstrated the existence of SP cells with the characteristics of TICs in uterine leiomyomas (24, 25) (Figs.”
BackgroundInfluentialHuang, B., Yang, M., Wang, P., Li, H.-Y., Chou, T., & Chen, Y. (2016) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-016-0200-y · Cited by 34
“Since the published case reports of PM after laparoscopic myomectomy, it was hypothesised that iatrogenic PMs could develop by seeding of retained small tissue fragments with stem cell after morcellation in the peritoneal cavity [22, 49].”
BackgroundSATB2 and NGR1: potential upstream regulatory factors in uterine leiomyomas
Sato, S., Maekawa, R., Tamura, I., Shirafuta, Y., Shinagawa, M., Asada, H., Taketani, T., Tamura, H., & Sugino, N. (2019) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-019-01582-y · Cited by 30
Patterson, A. L., George, J. W., Chatterjee, A., Carpenter, T. J., Wolfrum, E., Chesla, D. W., & Teixeira, J. M. (2019) · Human Reproduction · doi:10.1093/humrep/dez247 · Cited by 28
“Putative fibroid stem/progenitor cells have been shown to form larger tumours in vivo compared to non-stem/progenitor cells (Ono et al., 2012; Yin et al., 2015).”
BackgroundThe Emerging Spectrum of Early Life Exposure-Related Inflammation and Epigenetic Therapy
Yang, Q., Ali, M. K., Andaloussi, A. E., & Al-Hendy, A. A. (2018) · Cancer Studies and Molecular Medicine - Open Journal · doi:10.17140/csmmoj-4-125 · Cited by 37
Koltsova, A. S., Efimova, O. A., & Pendina, A. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065752 · Cited by 35
“In culture conditions, ULs form fewer colonies of non-differentiated cells, and the cells, in turn, have a shorter cell cycle [27,29,30].”
BackgroundInfluentialReview: Human uterine stem/progenitor cells: Implications for uterine physiology and pathology
Maruyama, T., Miyazaki, K., Masuda, H., Ono, M., Uchida, H., & Yoshimura, Y. (2013) · Placenta · doi:10.1016/j.placenta.2012.12.010 · Cited by 31
“Recently, it has been reported that SP cells are also present in leiomyoma [41e43], and that leiomyoma SP cells have the capacity to generate leiomyomas [42].”
BackgroundSelf-citationRANKL/RANK pathway and its inhibitor RANK-Fc in uterine leiomyoma growth
Ikhena, D. E., Liu, S., Kujawa, S., Esencan, E., Coon, J. S., Robins, J., Bulun, S. E., & Yin, P. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01585 · Cited by 26
Self-citationBanerjee, S., Xu, W., Chowdhury, I., Driss, A., Ali, M. K., Yang, Q., Al-Hendy, A. A., & Thompson, W. E. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-00960-9 · Cited by 29
Sabeh, M. E., Afrin, S., Singh, B., Miyashita‐Ishiwata, M., & Borahay, M. A. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10075-w · Cited by 30
“Stem cells derived from leiomyomas, unlike those derived from the myometrium, carry the MED12 mutations, a mutation present in up to 70% of leiomyomas [107, 128].”
BackgroundInfluentialBuyukcelebi, K., Chen, X., Abdula, F., Elkafas, H., Duval, A. J., Öztürk, H., Seker-Polat, F., Jin, Q., Yin, P., Yue, F., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39684-y · Cited by 33
“Notably, cell sorting analysis of UFs indicates a presence of a stem-like population that harbors MED12 mutations and can drive in vivo growth of leiomyoma xenograft tumors 57,58 .”
Self-citationOrganotypic culture as a research and preclinical model to study uterine leiomyomas
Salas, A., López, J., Reyes, R., Évora, C., de Oca, F. M., Báez, D., Delgado, A., & Almeida, T. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-62158-w · Cited by 32
Identification of pluripotent cells in bovine uterus: in situ and in vitro studies
Łupicka, M., Bodek, G., Shpigel, N. Y., Elnekave, E., & Korzekwa, A. J. (2015) · Reproduction · doi:10.1530/rep-14-0348 · Cited by 28
“Recent studies have also pointed out the presence of stem cells in the myometrial layer of the human uterus as well, where they contribute to uterine remodeling, especially during pregnancy (Ono et al. 2012, Maruyama et al. 2013).”
BackgroundUnno, K., Ono, M., Winder, A., Maniar, K. P., Paintal, A., Yu, Y., Wei, J., Lurain, J. R., & Kim, J. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0116064 · Cited by 26
“These include human endometrial and leiomyoma tissues [14–16], prostate cancer, breast tissues [17, 18], ovarian tumor tissues [19, 20].”
BackgroundSelf-citationБаранов, В. С., Ivaschenko, T. E., & Yarmolinskaya, M. I. (2016) · Systems Biology in Reproductive Medicine · doi:10.3109/19396368.2015.1123325 · Cited by 28
“Apparently, both mutations do not overlap with each other [Bertsch et al. 2014] and seem to be associated with different tumor sizes [Ono et al. 2012] as well as with their presence as multiple versus solitary tumors [Markowski et al. 2014; Osinovskaya et al. 2015].”
BackgroundMethodInfluentialNew and Emerging Therapies for Uterine Fibroids
Fritton, K., & Borahay, M. A. (2017) · Seminars in Reproductive Medicine · doi:10.1055/s-0037-1606303 · Cited by 24
Ciebiera, M., Włodarczyk, M., Wrzosek, M., Słabuszewska-Jóźwiak, A., Nowicka, G., & Jakiel, G. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.11.023 · Cited by 29
Reoperation rates for recurrence of fibroids after abdominal myomectomy in women with large uterus
Kramer, K. J., Ottum, S., Gonullu, D. C., Bell, C., Ozbeki, H., Berman, J. M., & Recanati, M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0261085 · Cited by 23
“A mutation in MED12 or HMGA2 [33] in myometrial stem cells [34] may be the precipitating event.”
BackgroundZanolli, N. C., Bishop, K. C., Kuller, J. A., Price, T. M., & Harris, B. S. (2022) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000001052 · Cited by 23
“HMGA1 and 2 (high-mobility group AT-hook) genes encode small nonhistone chromatinbinding proteins that play a role in inactivation of p53induced apoptosis and impairment of DNA repair.(26)”
BackgroundFernung, L. P., Al-Hendy, A. A., & Yang, Q. (2019) · Reproductive Sciences · doi:10.1177/1933719118783252 · Cited by 27
Role of DNA damage and repair mechanisms in uterine fibroid/leiomyomas: a review
Toprani, S. M., & Mane, V. K. (2020) · Biology of Reproduction · doi:10.1093/biolre/ioaa157 · Cited by 25
Liu, S., Yin, P., Xu, J., Dotts, A. J., Kujawa, S. A., Coon, J. S., Zhao, H., Shilatifard, A., Dai, Y. D., & Bulun, S. E. (2020) · Endocrinology · doi:10.1210/endocr/bqaa143 · Cited by 23
Self-citationActivation of protein kinase B by WNT4 as a regulator of uterine leiomyoma stem cell function
Liu, S., Yin, P., Dotts, A. J., Kujawa, S. A., Coon, J. S., Wei, J., Chakravarti, D., & Bulun, S. E. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.06.045 · Cited by 23
Self-citationNeri, M., Melis, G. B., Giancane, E., Vallerino, V., Pilloni, M., Piras, B., Loddo, A., Paoletti, A. M., & Mais, V. (2019) · International Journal of Women s Health · doi:10.2147/ijwh.s185023 · Cited by 20
“In vitro studies hypothesize that myomas originate from a single-mutated myometrial stem cell that acquires the capacity to proliferate, differentiate into smooth-muscle cells and produce extracellular matrix.(23,24) Different endocrine and paracrine factors can be involved in myomas growth, with ovarian steroids that…”
BackgroundSingh, P., Metkari, S., & Bhartiya, D. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10279-8 · Cited by 19
“Even MSCs isolated from leiomyoma express barely detectable levels of ERα and PR [20, 21].”
BackgroundAn HMGA2‐p62‐ERα axis regulates uterine leiomyomas proliferation
Liu, B., Chen, G., He, Q., Liu, M., Gao, K., Cai, B., Qu, J., Lin, S., Geng, A., Li, S., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000520r · Cited by 23
Moravek, M. B., Yin, P., Coon, J. S., Ono, M., Druschitz, S. A., Malpani, S. S., Dyson, M. T., RADEMAKER, A. W., Robins, J. C., Wei, J., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3497 · Cited by 18
“side population and CD34/CD49b cells (3, 6), we”
BackgroundSelf-citationVilaprisan for treating uterine fibroids
Melis, G. B., Neri, M., Piras, B., Paoletti, A. M., AJOSSA, S., Pilloni, M., Marotto, M. F., Corda, V., Saba, A., Giancane, E., et al. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1471134 · Cited by 18
“Different data support the hypothesis that a mutation of a myometrial stem cell is at the origin of this benign growth, favoring an uncontrolled cell self-regeneration, a differentiation into mature fibroid smooth-muscle cell, and the formation of extracellular matrix, under the influence of endocrine and paracrine fa…”
BackgroundIdentification and potential role of telocytes in human uterine leiomyoma
Othman, E. R., Elgamal, D. A., Refaiy, A. M., Abdelaal, I. I., Abdel-Mola, A. F., & Al-Hendy, A. A. (2016) · Contraception and Reproductive Medicine · doi:10.1186/s40834-016-0022-5 · Cited by 17
“However, the side population of fibroid stem cells contains very little amounts of steroid hormone receptors [41, 42].”
BackgroundAlpha-Tocopherol Serum Levels Are Increased in Caucasian Women with Uterine Fibroids: A Pilot Study
Ciebiera, M., Szymańska, J., Sentkowska, A., Kilian, K., Rogulski, Z., Nowicka, G., Jakiel, G., Tomaszewski, P., & Włodarczyk, M. (2018) · BioMed Research International · doi:10.1155/2018/6793726 · Cited by 18
“The paracrine effect of steroid hormones greatly affects the entire process of myometrial transformation [3, 22, 51].”
Fernung, L. P., Jones, K., Mas, A., Kleven, D. T., Waller, J. L., & Al-Hendy, A. A. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.06.023 · Cited by 16
Yang, Q. (2016) · Cell Stem cells and Regenerative Medicine · doi:10.16966/2472-6990.e103 · Cited by 14
“Taken together, emerging studies suggest that the developmental exposure to EDs and other toxins may result in genetic/epigenetic alterations and aberrant niche of MSCs, thereby converting the MSCs to tumor-initiating cells via a variety of signaling pathways.”
Emerging Roles of Long Non-coding RNAs in Uterine Leiomyoma Pathogenesis: a Review
Falahati, Z., Mohseni‐Dargah, M., & Mirfakhraie, R. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00571-w · Cited by 13
“Accordingly, it has been suggested that the function of fibroid SCs depends on paracrine signaling from adjacent mature myometrial and fibroid cells to facilitate the performance of estrogen and progesterone [29, 30].”
BackgroundRacial differences in transcriptomics and reactive oxygen species burden in myometrium and leiomyoma
Li, Y., McNally, R. P., Yue, F., Kim, J. J., & Wei, J. (2023) · Human Reproduction · doi:10.1093/humrep/dead020 · Cited by 14
Epigenetic Modulation of Inflammatory Pathways in Myometrial Stem Cells and Risk of Uterine Fibroids
Yang, Q., Ali, M. K., Treviño, L. S., Mas, A., Ismail, N., & Al-Hendy, A. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411641 · Cited by 14
Nonobese diabetic/severe combined immunodeficient murine xenograft model for human uterine leiomyoma
Wang, G., Ishikawa, H., Sone, K., Kobayashi, T., Kim, J. J., Kurita, T., & Shozu, M. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.01.054 · Cited by 14
Self-citationPatterson, A. L., George, J. W., Chatterjee, A., Carpenter, T. J., Wolfrum, E., Pru, J. K., & Teixeira, J. M. (2018) · Stem Cells and Development · doi:10.1089/scd.2018.0146 · Cited by 14
The CD24hi smooth muscle subpopulation is the predominant fraction in uterine fibroids
Drosch, M., Schmidt, N., Markowski, D. N., Zollner, T. M., Koch, M., & Bullerdiek, J. (2014) · Molecular Human Reproduction · doi:10.1093/molehr/gau022 · Cited by 12
CXCL12 Attracts Bone Marrow-Derived Cells to Uterine Leiomyomas
Moridi, I., Mamillapalli, R., Kodaman, P. H., Habata, S., Dang, T. C., & Taylor, H. S. (2020) · Reproductive Sciences · doi:10.1007/s43032-020-00166-x · Cited by 12
Carbajo‐García, M. C., de Miguel–Gómez, L., Juárez‐Barber, E., Trelis, A., Monleón, J., Pellicer, A., Flanagan, J. M., & Ferrero, H. (2022) · Biomedicines · doi:10.3390/biomedicines10061279 · Cited by 11
“Estrogen and progesterone act on the tissue’s mature cells and, through them, send paracrine factors to the stem cell population inducing its proliferation [11].”
BackgroundYang, Q., Ali, M. K., Treviño, L. S., Mas, A., & Al-Hendy, A. A. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04919-0 · Cited by 12
“Notably, one of the main differences between myometrial stem cells (MMSCs) and UFICs is at the genetic level, since specific mutations in MED12 observed in UFICs, are not present in MMSCs [19].”
BackgroundMozzachio, K., Moore, A. B., Kissling, G. E., & Dixon, D. (2015) · Toxicologic Pathology · doi:10.1177/0192623315621414 · Cited by 12
“Somatic stem cells have been isolated and appear to be necessary for steroid hormone–dependent growth (Mas et al. 2012; Ono et al. 2012).”
BackgroundIdentification of Differentially Expressed K-Ras Transcript Variants in Patients With Leiomyoma
Zolfaghari, N., Shahbazi, S., Torfeh, M., Khorasani, M., Hashemi, M., & Mahdian, R. (2017) · Reproductive Sciences · doi:10.1177/1933719116689596 · Cited by 10
“A study has proven that the transfer of leiomyoma stem cells under the kidney capsule of immunosuppressed mice leads to growth of the tumors.(2) Nevertheless, considerable evidence now supports the concept that development of uterine fibroids is the result of various factors, including genetic susceptibility, environm…”
BackgroundMediator's Kinase Module: A Modular Regulator of Cell Fate
Straub, J. A., Venigalla, S., & Newman, J. J. (2020) · Stem Cells and Development · doi:10.1089/scd.2020.0164 · Cited by 10
Endocrine-Disrupting Chemicals and Vitamin D Deficiency in the Pathogenesis of Uterine Fibroids
Elkafas, H., Badary, O. A., Morsy, E. M. E., Kamel, R., Yang, Q., & Al-Hendy, A. A. (2021) · Journal of Advanced Pharmacy Research · doi:10.21608/aprh.2021.66748.1124 · Cited by 13
The ontogeny of myometrial stem cells in OCT4-GFP transgenic mouse model
Brakta, S., Mas, A., & Al-Hendy, A. A. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1079-7 · Cited by 14
Receptivity-based uterine fibroid surgery: an updated systematic review of the evidence
Çelik, Ö., Koç, Ö., Yurci, A., Erşahin, A., Çelik, N., Çağiran, F. T., GÜRKAN, N., Özyurt, R., Özçil, M. D., Duran, B., et al. (2022) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog4905114 · Cited by 8
“Unlike the well and moderately differentiated fibroid cells that make up the fi-broid core, fibroid stem progenitor cells contain very few estrogen receptor (ER) and progesterone receptor (PR) [20– 22].”
BackgroundÇelik, Ö., Çelik, N., GÜNGÖR, N. D., Çelik, S., Arslan, L., Morciano, A., & Tinelli, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214201 · Cited by 9
“This growth is probably mediated by receptors on differentiated myometrial and leiomyoma cells [35,36].”
BackgroundTohya, T., Tajima, T., Takeshita, Y., Ito, K., Kuriwaki, K., & Katabuchi, H. (2014) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.12424 · Cited by 8
A Role for Progesterone-Regulated sFRP4 Expression in Uterine Leiomyomas
Delaney, M. A., Wan, Y., Kim, G.-E., Creighton, C. J., Taylor, M. G., Masand, R. P., Park, A., Valdés, C. T., Gibbons, W. E., Liu, Z., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-4014 · Cited by 8
“myometrium and uterine leiomyomas (36).”
Yang, Q., Ali, M. K., Bariani, M. V., Vafaei, S., & Al-Hendy, A. A. (2023) · Science Progress · doi:10.1177/00368504231215601 · Cited by 7
Metadata
- Authors
- Ono, M., Qiang, W., Serna, V. A., Yin, P., Coon, J. S., Navarro, A., Monsivais, D., Kakinuma, T., Dyson, M., Druschitz, S., Unno, K., Kurita, T., & Bulun, S. E.
- Affiliations
- Northwestern University (US)
- Corresponding author
- Bulun, Serdar E.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-05-03
- Volume
- 7
- Issue
- 5
- Pages
- e36935
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3343011
- OpenAlex
- W2046521626
- Semantic Scholar
- 546a83c8bc3366b826a6171706241d9b4ac6c215
- Cited by
- 141
- References
- 45
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 7 · 2023: 11 · 2022: 9 · 2021: 9 · 2020: 14 · 2019: 9 · 2018: 16 · 2017: 9 · 2016: 10 · 2015: 15 · 2014: 16 · 2013: 10
- FWCI
- 15.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Northwestern University (CA060553, NCI CA060553)
- National Institutes of Health (CA-060553, NCI CA060553)
- National Cancer Institute (CA 060553, NCI CA060553, R01CA154358, P30CA060553)
- National Institute of General Medical Sciences (R25GM079300)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P01HD057877, R01HD064402)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
- Health Sciences › Medicine › Urology › Urologic and reproductive health conditions
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- uterine fibroids, stem cells, side population cells, tumor growth, myometrium, estrogen receptor alpha, progesterone receptor, smooth muscle cells, xenografts, steroid hormone signaling, paracrine effects, oncogenic transformation
- MeSH terms
- Adult, Animals, Antigens, Surface, Base Sequence, Blood Cells, Bone Marrow Cells, Cell Cycle, Cell Differentiation, Cell Transformation, Neoplastic, Female, Humans, Leiomyoma, Middle Aged, Mutation, Myometrium, Neoplastic Stem Cells, Uterine Neoplasms, Mice, SCID, Mice, Inbred NOD, Coculture Techniques, Cell Lineage, Myocytes, Smooth Muscle, Cell Proliferation, Mice, Mediator Complex, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.